InflaRx (IFRX) Price to Sales (2023 - 2026)

InflaRx has disclosed Price to Sales across 4 years of filings, most recently posting 3533.08 for Q2 2026.

• In Q2 2026, Price to Sales rose 236.34% year-over-year to 3533.08; the TTM figure through Jun 2026 stood at 2054.21 (up 855.39% YoY), while the FY2025 annual figure was 2203.35, up 166.27% from the prior year.
• Price to Sales came in at 3533.08 for Q2 2026 at InflaRx, up from 1848.63 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 39022.52 in Q4 2023 to a low of 324322.09 in Q4 2024.
• Average Price to Sales over 4 years is 23468.63, with a median of 2012.66 recorded in 2023.
• Year-over-year, Price to Sales sank 931.12% in 2024 and jumped 330.9% in 2025.
• Over 4 years, Price to Sales stood at 39022.52 in 2023, then slumped by 931.12% to 324322.09 in 2024, then jumped by 99.43% to 1848.63 in 2025, then jumped by 291.12% to 3533.08 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 3533.08 in Q2 2026, 1848.63 in Q4 2025, and 2854.82 in Q3 2025.